United States · FDA National Drug Code directory
Ribavirinum
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 37662-4142_078e2ef1-2e1e-f8c3-e063-6394a90a145e
- Product NDC
- 37662-4142
- Form
- PELLET
- Composition / generic term
- Ribavirinum
- Labeler
- Hahnemann Laboratories, INC.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start / end (source format)
- 20231012
- Source listing expiry
- 20261231
Source-listed ingredients
- RIBAVIRIN — 1 [hp_M]/1
These values do not establish equivalence or a dose recommendation.
Packages
- 200 PELLET in 1 VIAL, GLASS (37662-4142-1) · 37662-4142-1
- 500 PELLET in 1 VIAL, GLASS (37662-4142-2) · 37662-4142-2
- 3000 PELLET in 1 BOTTLE, GLASS (37662-4142-3) · 37662-4142-3
- 10000 PELLET in 1 BOTTLE, GLASS (37662-4142-4) · 37662-4142-4
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →